52 related articles for article (PubMed ID: 20528532)
1. Cost-effectiveness of carbamazepine in epilepsy.
Heaney D; Sander JW
Expert Rev Pharmacoecon Outcomes Res; 2006 Feb; 6(1):13-8. PubMed ID: 20528532
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of pregabalin: a UK perspective.
Johnston A; Hamandi K
Expert Rev Pharmacoecon Outcomes Res; 2007 Aug; 7(4):327-33. PubMed ID: 20528414
[TBL] [Abstract][Full Text] [Related]
3. [The clinical and economic impact of generic drugs in the treatment of epilepsy].
Argumosa A; Herranz JL
Rev Neurol; 2005 Jul 1-15; 41(1):45-9. PubMed ID: 15999330
[TBL] [Abstract][Full Text] [Related]
4. Economic burden associated with the use of generic antiepileptic drugs in the United States.
Helmers SL; Paradis PE; Manjunath R; Duh MS; Lafeuille MH; Latrémouille-Viau D; Lefebvre P; Labiner DM
Epilepsy Behav; 2010 Aug; 18(4):437-44. PubMed ID: 20580619
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of first-line antiepileptic drug treatments in the developing world: a population-level analysis.
Chisholm D;
Epilepsia; 2005 May; 46(5):751-9. PubMed ID: 15857443
[TBL] [Abstract][Full Text] [Related]
6. Patterns of care, outcomes, and direct health plan costs of antiepileptic therapy: a pharmacoeconomic analysis of the available carbamazepine formulations.
Garnett WR; Gilbert TD; O'Connor P
Clin Ther; 2005 Jul; 27(7):1092-103. PubMed ID: 16154489
[TBL] [Abstract][Full Text] [Related]
7. Statin's cost-effectiveness: a Canadian analysis of commonly prescribed generic and brand name statins.
Tran YB; Frial T; Miller PS
Can J Clin Pharmacol; 2007; 14(2):e205-14. PubMed ID: 17556788
[TBL] [Abstract][Full Text] [Related]
8. Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability.
Alvarez N; Besag F; Iivanainen M
J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():1-15. PubMed ID: 10030426
[TBL] [Abstract][Full Text] [Related]
9. Generic substitution of anti-epileptic drugs. A needed battle?
Al-Baradie RS
Neurosciences (Riyadh); 2008 Jul; 13(3):211-6. PubMed ID: 21063327
[TBL] [Abstract][Full Text] [Related]
10. A Markov model of treatment of newly diagnosed epilepsy in the UK. An initial assessment of cost-effectiveness of topiramate.
Remák E; Hutton J; Price M; Peeters K; Adriaenssen I
Eur J Health Econ; 2003 Nov; 4(4):271-8. PubMed ID: 15609195
[TBL] [Abstract][Full Text] [Related]
11. Attitudes of Slovene general practitioners towards generic drug prescribing and comparison with international studies.
Kersnik J; Peklar J
J Clin Pharm Ther; 2006 Dec; 31(6):577-83. PubMed ID: 17176362
[TBL] [Abstract][Full Text] [Related]
12. Antiepileptic drug utilisation and seizure outcome among paediatric patients in a Malaysian public hospital.
Hasan SS; Bahari MB; Babar ZU; Ganesan V
Singapore Med J; 2010 Jan; 51(1):21-7. PubMed ID: 20200771
[TBL] [Abstract][Full Text] [Related]
13. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
Allen D; Rixson L
Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
[TBL] [Abstract][Full Text] [Related]
14. Oxcarbazepine: new preparation. An alternative to carbamazepine in partial epilepsy.
Prescrire Int; 2001 Dec; 10(56):170-4. PubMed ID: 11824439
[TBL] [Abstract][Full Text] [Related]
15. The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence.
Duh MS; Cahill KE; Paradis PE; Cremieux PY; Greenberg PE
Expert Opin Pharmacother; 2009 Oct; 10(14):2317-28. PubMed ID: 19663636
[TBL] [Abstract][Full Text] [Related]
16. Current approaches to the use of generic antiepileptic drugs.
Krämer G; Biraben A; Carreno M; Guekht A; de Haan GJ; Jedrzejczak J; Josephs D; van Rijckevorsel K; Zaccara G
Epilepsy Behav; 2007 Aug; 11(1):46-52. PubMed ID: 17537678
[TBL] [Abstract][Full Text] [Related]
17. Drugs for STD management in developing countries: choice, procurement, cost, and financing.
Van der Veen F; Fransen L
Sex Transm Infect; 1998 Jun; 74 Suppl 1():S166-74. PubMed ID: 10023369
[TBL] [Abstract][Full Text] [Related]
18. Carbamazepine in the treatment of epilepsy in people with intellectual disability.
Waisburg H; Alvarez N
J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():36-40. PubMed ID: 10030430
[TBL] [Abstract][Full Text] [Related]
19. Generic substitution in the treatment of epilepsy: patient and physician perceptions.
Berg MJ; Gross RA; Haskins LS; Zingaro WM; Tomaszewski KJ
Epilepsy Behav; 2008 Nov; 13(4):693-9. PubMed ID: 18589000
[TBL] [Abstract][Full Text] [Related]
20. [Prophylactic treatment of mood disorders: cost effectiveness analysis comparing lithium and carbamazepine].
Dardennes R; Lafuma A; Watkins S
Encephale; 1999; 25(5):391-400. PubMed ID: 10598301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
